Variant report
Variant | nsv1043869 |
---|---|
Chromosome Location | chr14:40968834-41044406 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574638030 | chr14:40980004-40980005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562603415 | chr14:40980016-40980017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537124877 | chr14:40980023-40980024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371637108 | chr14:40980028-40980029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9323025 | chr14:40980030-40980031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs577185963 | chr14:40980034-40980035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201364826 | chr14:40980055-40980056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552995172 | chr14:40980062-40980063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573054904 | chr14:40980071-40980072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139585890 | chr14:40980072-40980073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542089058 | chr14:40980091-40980092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569610010 | chr14:40980117-40980118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145548652 | chr14:40980133-40980134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530653293 | chr14:40980139-40980140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544337773 | chr14:40980145-40980146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372043020 | chr14:40980179-40980180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79905671 | chr14:40980216-40980217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532791330 | chr14:40980220-40980221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76677397 | chr14:40980288-40980289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566284238 | chr14:40980289-40980290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528756318 | chr14:40980329-40980330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548401181 | chr14:40980371-40980372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9323026 | chr14:40980393-40980394 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs9806011 | chr14:40980472-40980473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs17110871 | chr14:40980503-40980504 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs9323027 | chr14:40980535-40980536 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs9323028 | chr14:40980592-40980593 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs1958870 | chr14:40980599-40980600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539459876 | chr14:40980622-40980623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548943405 | chr14:40980630-40980631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567450465 | chr14:40980642-40980643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553325086 | chr14:40980661-40980662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200648764 | chr14:40980671-40980672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573224322 | chr14:40980672-40980673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35317347 | chr14:40980673-40980674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186315224 | chr14:40980688-40980689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555636755 | chr14:40980693-40980694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192077471 | chr14:40980720-40980721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144360313 | chr14:40980727-40980728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61462296 | chr14:40988835-40988836 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs570811062 | chr14:40988837-40988838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1959253 | chr14:40988853-40988854 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs57666397 | chr14:40988871-40988872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549244648 | chr14:40988873-40988874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142314726 | chr14:40988882-40988883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2050486 | chr14:40988919-40988920 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs112832911 | chr14:40988943-40988944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2783774 | chr14:40988947-40988948 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs377233121 | chr14:40988961-40988962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537595275 | chr14:40988985-40988986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21298110 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:40980000-40980800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr14:40988800-40989200 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr14:40994400-40994800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr14:40994400-40994800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr14:40994800-40997600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr14:40997600-40998000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr14:41042400-41042600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr14:41042400-41042600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr14:41042600-41046200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr14:41042800-41043800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr14:41043800-41044400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr14:41043800-41044400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr14:41043800-41044400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr14:41044000-41044200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr14:41044000-41044400 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr14:41044000-41044400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr14:41044000-41044600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr14:41044200-41044400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr14:41044400-41045400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr14:41044400-41046000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |